MYX mayne pharma group limited

Buried in pg 9:"The NEXTSTELLIS reassessment was a result of...

  1. 203 Posts.
    lightbulb Created with Sketch. 109
    Buried in pg 9:

    "The NEXTSTELLIS reassessment was a result of various market conditions differing from the original business case. These include the impact of COVID, the longer time for physician and patient activation, higher rates of prescription abandonment and the cost of insurance coverage."

    There's 2104 women on this prescription and we have a higher rate of abandonment than expected??? WTF?!?!?

    I'm really concerned with write-downs associated with Nextstellis - according to Financials we are carrying $246m in branded woman's products.. OUCH!

    Sure with covid; market conditions suck; but in the ~9months since approval; surely if this was a market disruptor there would be more traction by now. Based on these results, and this report alone - CEO and CPotB would be removed from any well run company. Give the B a chance; and this board has beaten this dead duck to death - but HOW does SR survive? Will only Kryptonite remove him?

    Next 6 months are going to hurt as without market guidance, these financials are not going to attract major investors...
    Last edited by Dickkyboy: 28/02/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
0.080(1.63%)
Mkt cap ! $406.2M
Open High Low Value Volume
$4.93 $5.10 $4.93 $3.062M 610.2K

Buyers (Bids)

No. Vol. Price($)
2 67102 $5.00
 

Sellers (Offers)

Price($) Vol. No.
$5.05 5000 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.